Updates in Cutaneous Adnexal Tumors

The talk focuses on the latest updates regarding cutaneous adnexal tumors, specifically non-melanocytic ones. The speaker highlights the significance of digital papillary adenocarcinoma, primarily driven by HPV type 42, noting that this discovery allows for more accurate diagnoses. Evidence shows that HPV 42, previously considered low-risk, may behave similarly to high-risk HPV in promoting cell proliferation. Techniques such as immunohistochemistry can aid in diagnosis, and the speaker emphasizes considering this tumor in genital skin lesions. Moving on, findings regarding the poroid family of tumors are discussed, including the utility of NUT antibodies in differentiating between malignant types and clarifying cases that could be confused with digital papillary adenocarcinoma. New insights into distinguishing ecrine from apocrine tumors based on genetic fusions and embryological differences were introduced. The speaker also covers nut adnexal carcinomas, clarifying their distinct characteristics from porocarcinomas despite having NUT fusions and noting that while aggressive forms exist in other tissues, cutaneous types typically exhibit less aggressive behavior. Overall, the discussion underscores the advanced understanding of genetic underpinnings in adnexal tumors, the improvement in diagnostic techniques, and the need for careful histopathological assessment.